Guardant Health, Inc. (NASDAQ:GH) is one of the 10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen. On May 8, Evercore ISI analyst Vijay Kumar raised Guardant Health, Inc.

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced the pricing of its upsized offering of $350.0 million ...

Diagnostics company Guardant Health (NASDAQ:GH) reported Q1 CY2026 results , with sales up 48.3% year on year to $301.7 ...

Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.

Guardant Health (NASDAQ:GH) reported a strong start to 2026, citing accelerating adoption across its oncology, biopharma and ...

Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.

Guardant Health (GH) reported $301.67 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 48.3%. EPS of -$0.45 for the same period compares to -$0.49 a year ...

Guardant Health (NASDAQ: GH) is on the rise, in more ways than one. Shares of the precision oncology company have skyrocketed over the last six months. Guardant Health has also chalked up several key ...

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (GH), a leading precision oncology company, today announced the company and its research collaborators will present 28 abstracts, including 3 ...

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A ...

Q1 2026 earnings call: 48% revenue growth, Shield/Reveal momentum, Quest rollout, and raised 2026 guidance—read key takeaways now.

A federal court jury has sided with Guardant Health, which had claimed that rival cancer test developer Natera went too far in advertisements for its competing assay to monitor patients for the return ...